The team behind Antibiogo

Where it all started

Antibiogo is the initiative of Nada Malou, a doctor specialized in AMR and access to diagnostics. Seeing the urgency in the antibiotics resistance situation, she put together a project within the MSF Foundation to act.

Ambulance

1. Antimicrobial resistance is a global and urgent issue

AMR, recognized as a public health concern since the 1940s, continues to escalate as infections increasingly resist antibiotics. This challenge is particularly pressing in LMICs. Historically, the lack of access to diagnostics in LMICs has obscured the extent of AMR. At organizations like MSF, we often encounter patients suffering from seemingly minor infections that could be easily treatable with access to proper diagnostics. Closing this gap in diagnostic access is crucial for effective management of AMR and improving healthcare outcomes worldwide.

Test tube

2. If one person loses, we all lose

AMR isn't a battle we face alone. In today's interconnected world, diseases spread rapidly. If even one lab lacks accurate technology for treatment, resorting to stronger antibiotics, it fuels resistance globally. Ensuring equity in access to accurate diagnostics and treatments is crucial. Additionally, there's a pressing need for the development of diagnostic tests by and for the Global South, addressing the unique challenges faced by these regions.

Grooming

3. The need for a multidisciplinary approach

MSF's experience shows that while machines are crucial for diagnostics, it's empowering lab technicians with training that truly makes a difference. We firmly believe in the importance of human capacity building alongside diagnostic tools in combating AMR effectively. That is why Antibiogo comes with a training programme, accessible to all those who want it.

Made by lab techs, for lab techs and by doctors, for doctors.

Get to know the experts we collaborated with to bring you this game-changing digital health tool.

Médecins Sans Frontières logo

Médecins Sans Frontières

Médecins Sans Frontières is an international humanitarian organization that has been providing medical aid in conflict zones, natural disasters, and epidemics worldwide for 60+ years.
Fondation Médecins Sans Frontières logo

The MSF Foundation

The MSF Foundation is a branch of Médecins Sans Frontières dedicated to innovation and research to improve the effectiveness of humanitarian medical aid.
i2a logo

i2a

i2a Diagnostics develops innovative microbiological diagnostic systems, including automated agar-based antibiogram readers, to improve lab efficiency and patient care.
Laboratoire de Mathématiques et Modélisation d'Évry logo

Laboratoire de Mathématiques et Modélisation d'Évry

LaMME conducts advanced research in mathematical analysis, probabilities, and statistics, applying these to fields such as finance, genomics, and life sciences.
Henri Mondor Hospital logo

Henri Mondor Hospital

The Henri Mondor Hospital is a major teaching hospital offering a wide range of medical services and specializing in advanced surgical and critical care.
UMR logo

UMR Genoscope Metabolic

The UMR Genoscope Metabolic at the Genoscope National Sequencing Center conducts genomic and metabolic research to explore biodiversity and chemical reactions for biotechnological and environmental applications.
Google logo

Google.org

In 2018, the MSF Foundation won the Google AI impact challenge, which provided the team with a grant and resources from google to work on developing Antibiogo.
EPFL logo

EPFL

The EPFL is a renowned Swiss university known for its cutting-edge research and education in science, engineering, and technology.
Aga Khan University logo

Aga Khan University Hospital, Nairobi, Kenya

Aga Khan University is renowned for its commitment to excellence in healthcare, education, and research, serving as a beacon of innovation and progress in East Africa.
CHU La Réunion logo

CHU La Réunion

The CHU La Réunion serves as a vital healthcare hub in the Indian Ocean region with a commitment to innovation and community well-being.
LOMWRU logo

Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit

LOMWRU is a collaborative powerhouse driving groundbreaking medical research in Laos, aiming to tackle infectious diseases and improve healthcare outcomes through innovative scientific inquiry and partnershipto work on developing Antibiogo.
Institut Pasteur de Dakar logo

Pasteur Institute, Dakar

The Pasteur Institute in Dakar is a leading research institution at the forefront of combating infectious diseases in Africa.

Meet the labs that supported the making of Antibiogo

To make Antibiogo not only the tool, but the multidisciplinary programme that it is today, we relied on the precious help and user testing of several MSF labs located in LMICs.

Yemen laboratory

MSF laboratory in Yemen

The MSF laboratory in Aden is the only bacteriology lab in the region that processes bones and tissues to diagnose war-related infections.

MSF bacteriology laboratory in Mali

The MSF bacteriology laboratory at Koutiala CSREF in Mali is the first of its kind for MSF France. The insights gained from this laboratory and the engagement of its users contributed to the development of Antibiogo.

A person doing an antibiotic susceptibility testing in a laboratory.
Jordan hospital

MSF reconstructive hospital in Jordan

The MSF reconstructive hospital in Amman, Jordan, houses the RSP laboratory, which is a critical facility for diagnosing war-related infections. This bacteriology laboratory plays a key role in supporting the multidisciplinary approach to antimicrobial resistance (AMR).

Want to give it a try?
Contact us to have early access to Antibiogo

Antibiogo will be released to the public at the end 2024, but we are offering early access to medical institutions.

Website intended for healthcare professionals

According to the provisions of the Code de la Santé Publique, this website is exclusively intended for healthcare professionals. Please certify that you are a healthcare professional.

A healthcare professional is any person authorized to prescribe, dispense, or use in vitro diagnostic medical devices in the exercise of their profession.

I certify